Full-Time

Specialist

LNP Process Development

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Mid

Norwood, MA, USA

70% in-office structure.

Category
Bioinformatics
Computational Biology
Biology & Biotech
Required Skills
Microsoft Azure
Python
Data Science
Apache Spark
SQL
AWS
Data Analysis
Requirements
  • Bachelor’s degree in Computer Science, Software Engineering or a related field.
  • 3+ years of experience in data science, analytics and mining with certification in cloud technologies.
  • Proficiency in SQL, Python, and data pipeline tools (e.g., Apache Spark).
  • Experience with cloud platforms (AWS, Azure) and big data technologies.
  • Strong problem-solving skills and attention to detail.
  • Ensure data quality, integrity, and security across systems.
  • Implement best practices for excising or developing data governance and management.
  • Proficiency in statistical analysis, machine learning, and data visualization.
  • Knowledge of data governance best practices.
  • Familiarity with FDA guidance and relevant CFR compliance requirements.
Responsibilities
  • Develop and maintain data pipelines to support LNP process development, delivery and process chemistry, specifically, but not limited to, small molecules.
  • Collaborate with process engineers and scientists to collect, analyze, and visualize data according to Moderna data governance initiatives.
  • Optimize data storage solutions for high-volume experimental data, in accordance with Moderna data governance across Technical Development, Digital, Research and Development, and Quantitative Sciences.
  • Create dashboards and reporting tools to visualize process metrics and outcomes.
  • Collaborate with scientist to interrogate inputs in data warehouses against external sources in the literature to inform risk assessments and de-risk overall upstream process robustness.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for various biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treatment options for patients. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to harness the power of mRNA to improve patient outcomes and create effective treatments for a range of diseases.

Company Stage

IPO

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

4%

1 year growth

16%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • mRNA technology is expanding into personalized cancer vaccines, revolutionizing treatment.
  • Recent advancements in lipid nanoparticle delivery enhance mRNA vaccine efficacy.
  • Global mRNA vaccine market projected to grow significantly, boosting Moderna's prospects.

What critics are saying

  • Potential exclusion from Nasdaq 100 could impact investor perception and liquidity.
  • Bypassing safety steps in Australia may raise regulatory scrutiny.
  • Geopolitical tensions in China pose operational and financial risks for Moderna.

What makes Moderna unique

  • Moderna is pioneering mRNA technology for a new class of medicines.
  • The company has developed one of the earliest and most effective COVID-19 vaccines.
  • Moderna's mRNA platform enables rapid development of vaccines for various diseases.

Help us improve and share your feedback! Did you find this helpful?